학술논문

Roles and therapeutic targeting of dendritic cells in liver fibrosis.
Document Type
Article
Source
Journal of Drug Targeting. Apr2024, p1-8. 8p. 3 Illustrations, 1 Chart.
Subject
Language
ISSN
1061-186X
Abstract
AbstractLiver fibrosis is a common pathological condition marked by excessive accumulation of extracellular matrix proteins, resulting in irreversible cirrhosis and cancer. Dendritic cells (DCs) act as the crucial component of hepatic immunity and are believed to affect fibrosis by regulating the proliferation and differentiation of hepatic stellate cells (HSCs), a key mediator of fibrogenesis, and by interplaying with immune cells in the liver. This review concisely describes the process of fibrogenesis, and the phenotypic and functional characteristics of DCs in the liver. Besides, it focuses on the interaction between DCs and HSCs, T cells, and natural killer (NK) cells, as well as the dual roles of DCs in liver fibrosis, for the sake of exploring the potential of targeting DCs as a therapeutic strategy for the disease. [ABSTRACT FROM AUTHOR]